Galderma (SIX: GALD) today announced two-year data from a new interim analysis of a long-term extension study investigating the saf ...

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib and abrocitinib.

New interim two-year data from a long-term extension study of Nemluvioin atopic dermatitis reinforce its rapid onset of action and demonstrate its ...

Other tips may include regularly moisturizing your skin and lowering your stress levels. Atopic dermatitis (AD), also known as eczema, is an inflammatory skin condition that may cause dry ...